Venter makes new hires at Synthetic Genomics and Human Longevity

J. Craig Venter has made new hires at two of his companies. Barry Merriman and Paul Mola have joined life-extension startup Human Longevity to pitch the company's capabilities to potential clients and partners, including foreign governments, national healthcare systems and health charities. Oliver Fetzer is the new face at Synthetic Genomics. Fetzer has replaced Venter as CEO. Release I More

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.